Perspective Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Perspective Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2024.
  • Perspective Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.43M, a 59.1% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.43M +$904K +59.1% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.02M +$1.21M +151% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.06M +$749K +242% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $747K +$747K Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $1.53M +$1.08M +244% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $805K +$293K +57.2% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $309K -$268K -46.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $0 -$642K -100% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $445K -$260K -36.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $512K -$256K -33.3% Jun 30, 2022 10-KT 2023-05-01
Q1 2022 $577K -$253K -30.5% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $642K -$249K -27.9% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 $705K -$246K -25.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $768K -$233K -23.3% Jun 30, 2021 10-KT 2023-05-01
Q1 2021 $830K -$229K -21.6% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $891K -$225K -20.2% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $951K -$221K -18.9% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $1M Jun 30, 2020 10-K 2021-09-27
Q1 2020 $1.06M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $1.12M Dec 31, 2019 10-Q 2020-02-12
Q3 2019 $1.17M Sep 30, 2019 10-Q 2019-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.